Casey M. Cosgrove, MD

Casey M. Cosgrove, MD, discusses utilizing biomarker-informed treatments in endometrial cancer.

Casey M. Cosgrove, MD, discusses the utilization of PARP inhibition in ovarian cancer.

Casey M. Cosgrove, MD, discusses the approval of niraparib in advanced ovarian cancer.

Casey M. Cosgrove, MD, gynecologic oncologist, The Ohio State University Comprehensive Cancer Center–James, and assistant professor, Department of Gynecologic Oncology, The Ohio State University College of Medicine, discusses retreatment with PARP inhibitors in recurrent ovarian cancer.

Casey M. Cosgrove, MD, discusses factors to consider when selecting a PARP inhibitor as maintenance therapy in advanced ovarian cancer.